Cholesteryl ester transfer protein facilitates the movement of water-insoluble drugs between lipoproteins: a novel biological function for a well-characterized lipid transfer protein

被引:16
作者
Kwong, M [1 ]
Wasan, KM [1 ]
机构
[1] Univ British Columbia, Fac Pharmaceut Sci, Div Pharmaceut & Biopharmaceut, Vancouver, BC V6T 1Z3, Canada
关键词
cholesteryl ester transfer protein; lipid transfer protein I; cyclosporine A; amphotericin B; drug movement and lipoproteins;
D O I
10.1016/S0006-2952(02)01392-8
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This review article addresses the recently discovered finding that cholesteryl ester transfer protein (CETP) can facilitate the transfer of water-insoluble drugs between different lipoprotein subclasses. This protein, which is often referred to as lipid transfer protein I (LTP 1), is involved in the lipid regulation of lipoproteins. It is responsible for the facilitated transfer of core lipoprotein lipids, cholesteryl ester and triglycerides, and approximately one-third of the coat lipoprotein lipid, phosphatidylcholine, between different plasma lipoproteins. The human body appears to recognize exogenous water-insoluble drugs as lipid-like particles, which suggests that these compounds may interact with lipoproteins just like endogenous plasma lipids, and thus their transfer between lipoproteins may be facilitated by plasma CETP. Patients with a variety of diseases (i.e. diabetes, cancer, AIDS) often exhibit hypo- and/or hypercholesterolemia and triglyceridemia, commonly referred to as dyslipidemias, which result in changes in their plasma lipoprotein-lipid composition and concentration. The interaction of water-insoluble drugs with these dyslipidemic lipoproteins may be responsible for the differences seen in the pharmacokinetics and pharmacodynamics of the drug within different diseased patient populations. It is possible that these differences may be linked to the ability of CETP to transfer these compounds from one lipoprotein to another. This review examines the current understanding of the relationship between CETP activity and the lipoprotein distribution of a number of compounds (e.g. amphotericin B and cyclosporine A). It further suggests that additional research will expand our understanding of the role of CETP to explain other functions in lipophilic drug distribution and metabolism. (C) 2002 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:1669 / 1675
页数:7
相关论文
共 45 条
[1]  
AWNI WM, 1985, DRUG METAB DISPOS, V13, P127
[2]  
BARTER PJ, 1980, J LIPID RES, V21, P238
[3]   CYCLOSPORINE, LOW-DENSITY LIPOPROTEIN, AND CHOLESTEROL [J].
DEGROEN, PC .
MAYO CLINIC PROCEEDINGS, 1988, 63 (10) :1012-1021
[4]   CENTRAL-NERVOUS-SYSTEM TOXICITY AFTER LIVER-TRANSPLANTATION - THE ROLE OF CYCLOSPORINE AND CHOLESTEROL [J].
DEGROEN, PC ;
AKSAMIT, AJ ;
RAKELA, J ;
FORBES, GS ;
KROM, RAF .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (14) :861-866
[5]  
DEKIPPEL N, 1992, LANCET, V339, P114
[6]   EFFECTS OF PLASMA-LIPID LEVELS ON BLOOD DISTRIBUTION AND PHARMACOKINETICS OF CYCLOSPORINE-A [J].
GARDIER, AM ;
MATHE, D ;
GUEDENEY, X ;
BARRE, J ;
BENVENUTTI, C ;
NAVARRO, N ;
VERNILLET, L ;
LOISANCE, D ;
CACHERA, JP ;
JACOTOT, B ;
TILLEMENT, JP .
THERAPEUTIC DRUG MONITORING, 1993, 15 (04) :274-280
[7]   DIFFERENCES IN PLASMA CHOLESTERYL ESTER TRANSFER ACTIVITY IN 16 VERTEBRATE SPECIES [J].
HA, YC ;
BARTER, PJ .
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY B-BIOCHEMISTRY & MOLECULAR BIOLOGY, 1982, 71 (02) :265-269
[8]  
HESLER CB, 1987, J BIOL CHEM, V262, P2275
[9]   PLASMA DISTRIBUTION OF CYCLOSPORINE WITHIN LIPOPROTEINS AND INVITRO TRANSFER BETWEEN VERY-LOW-DENSITY LIPOPROTEINS, LOW-DENSITY LIPOPROTEINS, AND HIGH-DENSITY-LIPOPROTEINS [J].
HUGHES, TA ;
GABER, AO ;
MONTGOMERY, CE .
THERAPEUTIC DRUG MONITORING, 1991, 13 (04) :289-295
[10]  
IHM J, 1982, J LIPID RES, V23, P1328